Author:
Pellicioli F.,Sala L.,Colonese F.,Belloni E.,Abbate M.I.,Canova S.,D'Agostino A.,Cortinovis D.L.
Reference33 articles.
1. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications;Forest;Pathology,2018
2. Cancer treatment and survivorship statistics, 2022;Miller;CA A Cancer J. Clin.,2022
3. Malignant mesothelioma;Jain,2023
4. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: a review of the National Cancer Database;Bou-Samra;Cancer Med.,2023
5. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations;Sejben;Thorac Cancer,2023